BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37523175)

  • 1. Psychosocial Impact of the Insulin-Only iLet Bionic Pancreas for Adults, Youth, and Caregivers of Youth with Type 1 Diabetes.
    Weissberg-Benchell J; Vesco AT; Shapiro J; Calhoun P; Damiano ER; Russell SJ; Li Z; El-Khatib FH; Ruedy KJ; Balliro CA; Beck RW
    Diabetes Technol Ther; 2023 Oct; 25(10):705-717. PubMed ID: 37523175
    [No Abstract]   [Full Text] [Related]  

  • 2. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
    Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
    [No Abstract]   [Full Text] [Related]  

  • 3. The Insulin-Only Bionic Pancreas Pivotal Trial Extension Study: A Multi-Center Single-Arm Evaluation of the Insulin-Only Configuration of the Bionic Pancreas in Adults and Youth with Type 1 Diabetes.
    Lynch J; Kanapka LG; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):726-736. PubMed ID: 36173238
    [No Abstract]   [Full Text] [Related]  

  • 4. A Multicenter Randomized Trial Evaluating the Insulin-Only Configuration of the Bionic Pancreas in Adults with Type 1 Diabetes.
    Kruger D; Kass A; Lonier J; Pettus J; Raskin P; Salam M; Trikudanathan S; Zhou K; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Marak MC; Calhoun P; Beck RW
    Diabetes Technol Ther; 2022 Oct; 24(10):697-711. PubMed ID: 36173236
    [No Abstract]   [Full Text] [Related]  

  • 5. A Multicenter Randomized Trial Evaluating Fast-Acting Insulin Aspart in the Bionic Pancreas in Adults with Type 1 Diabetes.
    Beck RW; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro C; Li Z; Calhoun P
    Diabetes Technol Ther; 2022 Oct; 24(10):681-696. PubMed ID: 36173235
    [No Abstract]   [Full Text] [Related]  

  • 6. Randomized Trial of the Insulin-Only iLet Bionic Pancreas for the Treatment of Cystic Fibrosis- Related Diabetes.
    Sherwood JS; Castellanos LE; O'Connor MY; Balliro CA; Hillard MA; Gaston SG; Bartholomew R; Greaux E; Sabean A; Zheng H; Marchetti P; Uluer A; Sawicki GS; Neuringer I; El-Khatib FH; Damiano ER; Russell SJ; Putman MS
    Diabetes Care; 2024 Jan; 47(1):101-108. PubMed ID: 37874987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utility and Safety of Backup Insulin Regimens Generated by the Bionic Pancreas: A Randomized Study.
    Mauras N; Damiano ER; El-Khatib FH; Marak MC; Calhoun P; Ruedy KJ; Balliro C; Li Z; Beck RW; Russell SJ
    Diabetes Technol Ther; 2023 Jun; 25(6):437-441. PubMed ID: 36877259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parent, child, and adolescent lived experience using the insulin-only iLet Bionic Pancreas.
    Howard KR; Garza KP; Feldman M; Weissberg-Benchell J
    J Pediatr Psychol; 2024 Jun; 49(6):413-420. PubMed ID: 38591792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
    El-Khatib FH; Balliro C; Hillard MA; Magyar KL; Ekhlaspour L; Sinha M; Mondesir D; Esmaeili A; Hartigan C; Thompson MJ; Malkani S; Lock JP; Harlan DM; Clinton P; Frank E; Wilson DM; DeSalvo D; Norlander L; Ly T; Buckingham BA; Diner J; Dezube M; Young LA; Goley A; Kirkman MS; Buse JB; Zheng H; Selagamsetty RR; Damiano ER; Russell SJ
    Lancet; 2017 Jan; 389(10067):369-380. PubMed ID: 28007348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of the Insulin-Only iLet Bionic Pancreas and the Bihormonal iLet Using Dasiglucagon in Adults With Type 1 Diabetes in a Home-Use Setting.
    Castellanos LE; Balliro CA; Sherwood JS; Jafri R; Hillard MA; Greaux E; Selagamsetty R; Zheng H; El-Khatib FH; Damiano ER; Russell SJ
    Diabetes Care; 2021 Jun; 44(6):e118-e120. PubMed ID: 33906916
    [No Abstract]   [Full Text] [Related]  

  • 11. Psychosocial Impact of the Bionic Pancreas During Summer Camp.
    Weissberg-Benchell J; Hessler D; Polonsky WH; Fisher L
    J Diabetes Sci Technol; 2016 Jul; 10(4):840-4. PubMed ID: 26993252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of an Automated Bihormonal Delivery System on Psychosocial Outcomes in Adults with Type 1 Diabetes.
    Weissberg-Benchell J; Hessler D; Fisher L; Russell SJ; Polonsky WH
    Diabetes Technol Ther; 2017 Dec; 19(12):723-729. PubMed ID: 29106311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Insulin-Only Bionic Pancreas Improves Glycemic Control in Non-Hispanic White and Minority Adults and Children With Type 1 Diabetes.
    Castellanos LE; Russell SJ; Damiano ER; Beck RW; Shah VN; Bailey R; Calhoun P; Bird K; Mauras N;
    Diabetes Care; 2023 Jun; 46(6):1185-1190. PubMed ID: 37000680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvements in Glycemic Control Achieved by Altering the t
    Russell SJ; Balliro C; Ekelund M; El-Khatib F; Graungaard T; Greaux E; Hillard M; Jafri RZ; Rathor N; Selagamsetty R; Sherwood J; Damiano ER
    Diabetes Ther; 2021 Jul; 12(7):2019-2033. PubMed ID: 34146238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial Outcomes Among Users and Nonusers of Open-Source Automated Insulin Delivery Systems: Multinational Survey of Adults With Type 1 Diabetes.
    Schipp J; Hendrieckx C; Braune K; Knoll C; O'Donnell S; Ballhausen H; Cleal B; Wäldchen M; Lewis DM; Gajewska KA; Skinner TC; Speight J
    J Med Internet Res; 2023 Dec; 25():e44002. PubMed ID: 38096018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychosocial and Human Factors During a Trial of a Hybrid Closed Loop System for Type 1 Diabetes Management.
    Adams RN; Tanenbaum ML; Hanes SJ; Ambrosino JM; Ly TT; Maahs DM; Naranjo D; Walders-Abramson N; Weinzimer SA; Buckingham BA; Hood KK
    Diabetes Technol Ther; 2018 Oct; 20(10):648-653. PubMed ID: 30239219
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Diabetes Technol Ther; 2022 Aug; 24(8):598. PubMed ID: 35776687
    [No Abstract]   [Full Text] [Related]  

  • 19. Psychosocial Effects of the Loop Open-Source Automated Insulin Delivery System.
    Wong JJ; Hood KK; Hanes SJ; Lal RA; Naranjo D
    J Diabetes Sci Technol; 2023 Nov; 17(6):1440-1447. PubMed ID: 35771004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing patient-reported outcomes for automated insulin delivery systems: the psychometric properties of the INSPIRE measures.
    Weissberg-Benchell J; Shapiro JB; Hood K; Laffel LM; Naranjo D; Miller K; Barnard K
    Diabet Med; 2019 May; 36(5):644-652. PubMed ID: 30761592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.